Innovative Eyewear Inc (LUCYW) stock
LUCYWNasdaqOphthalmic GoodsFiscal year ends December 31Also trades as LUCY
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Aug 14, 2026Score 12/3049% below fair value
$0.05−0.00 (-0.81%)
Close on Oct 30, 2026Market cap $7.15MP/E –Yield –
Innovative Eyewear r&d expenses
Research and development expenses are spending on new products and technology.
Innovative Eyewear's R&D Expenses for the twelve months ending Dec 31, 2024 was $819.39K, up 23.7% year over year. For fiscal 2025 it was $725.39K, down 11.5% from the year before. The highest annual figure on record is $819.39K in fiscal 2024.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $725.39K | -11.5% |
| FY2024 | Dec 31, 2024 | $819.39K | +23.7% |
| FY2023 | Dec 31, 2023 | $662.18K | +26.2% |
| FY2022 | Dec 31, 2022 | $524.69K | +508.3% |
| FY2021 | Dec 31, 2021 | $86.26K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | $138.11K | +14.3% |
| Q2 FY2025 | Jun 30, 2025 | $268.22K | +39.2% |
| Q1 FY2025 | Mar 31, 2025 | $210.58K | +6.6% |
| Q4 FY2024 | Dec 31, 2024 | $214.92K | +42.2% |
| Q4 FY2023 | Dec 31, 2023 | $120.84K | -8.2% |
| Q3 FY2023 | Sep 30, 2023 | $192.70K | -36.8% |
| Q2 FY2023 | Jun 30, 2023 | $197.48K | +275.7% |
| Q1 FY2023 | Mar 31, 2023 | $151.17K | +322.2% |
| Q4 FY2022 | Dec 31, 2022 | $131.63K | +162.5% |
| Q3 FY2022 | Sep 30, 2022 | $304.69K | +3203.2% |
| Q2 FY2022 | Jun 30, 2022 | $52.56K | +174.8% |
| Q1 FY2022 | Mar 31, 2022 | $35.81K | – |
| Q4 FY2021 | Dec 31, 2021 | $50.14K | – |
| Q3 FY2021 | Sep 30, 2021 | $9.22K | – |
| Q2 FY2021 | Jun 30, 2021 | $19.13K | – |